Synthetic Lethal Mutation Analysis of Yeast CP1
酵母 CP1 的合成致死突变分析
基本信息
- 批准号:9406050
- 负责人:
- 金额:$ 30万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Continuing Grant
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-08-01 至 1998-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
9406050 Baker CP1 (encoded by the gene CEP1) is a moderately abundant, sequence-specific DNA-binding protein of S. cerevisiae. A member of the general regulatory factor family of yeast chromosomal proteins, CP1 is multifunctional; it performs roles in chromosome segregation and in regulating gene expression. It is believed that CP1 acts primarily as a local organizer of chromatin structure, configuring the DNA into conformations conducive to the assembly of kinetochores and active transcription complexes. To learn more about CP1 action, a synthetic lethal genetic analysis of CP1 is being undertaken. Mutations synthetically lethal with cep1 will be isolated and complementation groups defined. The cep1 synthetic lethal mutations (csl's) will be classified by phenotype; the mutants will be tested for defects in mitotic and meiotic chromosome segregation, defects in transcription, synergistic interaction between the csl and a cis-acting centromere mutation, perturbations in cell cycle progression, and ability to be rescued by partially-active mutant alleles of cep1. Wild-type genes corresponding to the most interesting csl alleles will be isolated from yeast genomic plasmid libraries and characterized. %%% The long term goal of this research is to provide general insights into the biochemical mechanisms that establish eukaryotic chromosome structure and effect changes in that structure to meet functional needs. Chromosome structure is an essential element in both the regulation of gene expression and the proper distribution of chromosomes at cell division. ***
9406050 Baker CP 1(由基因CEP 1编码)是一种中等丰度的、序列特异性的S.啤酒。 CP 1是酵母染色体蛋白的一般调节因子家族的成员,是多功能的;它在染色体分离和调节基因表达中发挥作用。 据信,CP 1主要作为染色质结构的局部组织者,将DNA配置成有利于着丝粒和活性转录复合物组装的构象。 为了更多地了解CP 1的作用,目前正在对CP 1进行合成致死基因分析。 与cep 1合成致死的突变将被分离并定义互补组。 cep 1合成致死突变(csl's)将按表型分类;突变体将检测有丝分裂和减数分裂染色体分离缺陷、转录缺陷、csl和顺式作用着丝粒突变之间的协同作用、细胞周期进程扰动以及被cep 1部分活性突变等位基因拯救的能力。 将从酵母基因组质粒库中分离对应于最有趣的csl等位基因的野生型基因并进行表征。 这项研究的长期目标是提供建立真核细胞染色体结构的生化机制的一般见解,并影响该结构的变化,以满足功能需求。 染色体结构是调控基因表达和细胞分裂时染色体正确分布的基本要素。 ***
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard Baker其他文献
A systematic review of discharge arrangements for older people.
对老年人的出院安排进行系统审查。
- DOI:
10.3310/hta6040 - 发表时间:
2002 - 期刊:
- 影响因子:3.6
- 作者:
Stuart G Parker;S. Peet;A. McPherson;A. Cannaby;K. Abrams;Richard Baker;Amanda Wilson;J. Lindesay;Gordon Parker;David R. Jones - 通讯作者:
David R. Jones
The Biology of Major Histocompatibility Complex Molecules—I
主要组织相容性复杂分子的生物学-I
- DOI:
10.1016/b978-012440315-4/50078-1 - 发表时间:
2000 - 期刊:
- 影响因子:2.6
- 作者:
Richard Baker;A. Warrens - 通讯作者:
A. Warrens
A checklist for identifying determinants of practice: A systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice
- DOI:
10.1186/1748-5908-8-35 - 发表时间:
2013-03-23 - 期刊:
- 影响因子:13.400
- 作者:
Signe A Flottorp;Andrew D Oxman;Jane Krause;Nyokabi R Musila;Michel Wensing;Maciek Godycki-Cwirko;Richard Baker;Martin P Eccles - 通讯作者:
Martin P Eccles
Tumor Embolic Stroke: The Importance of Pathological Assessment of Clots after Thrombectomy
肿瘤栓塞性中风:血栓切除术后血栓病理评估的重要性
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:3.9
- 作者:
Richard Baker;Zohabe Bakali;Jeffrey S. Crocker;A. Mowla;Matthew Smith;Aaron Grossman;Matthew C. Hagen;Charles J. Prestigiacomo;P. Shirani - 通讯作者:
P. Shirani
First episode mania following cessation of varenicline (Champix)
停止伐尼克兰后首次发作的躁狂症(Champix)
- DOI:
- 发表时间:
2016 - 期刊:
- 影响因子:1.8
- 作者:
Richard Baker;N. Gill;G. Parker - 通讯作者:
G. Parker
Richard Baker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard Baker', 18)}}的其他基金
IntBIO: Collaborative Research: Silk Protein Innovation and Novelty (SPIN) : integrating across disciplines to decipher silk fiber evolution
IntBIO:合作研究:丝蛋白创新与新颖(SPIN):跨学科整合,破译丝纤维的进化
- 批准号:
2217158 - 财政年份:2022
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
Collaborative Research: Origin and Evolution of the X and Y Chromosomes in Stalk-eyed Flies
合作研究:茎眼果蝇 X 和 Y 染色体的起源和进化
- 批准号:
0951816 - 财政年份:2010
- 资助金额:
$ 30万 - 项目类别:
Continuing Grant
SBIR Phase I: Closed Loop Solvent Evaporation Ovens
SBIR 第一阶段:闭环溶剂蒸发炉
- 批准号:
9961229 - 财政年份:2000
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
SBIR Phase I: On-Site Production of Hydrogen
SBIR 第一阶段:现场制氢
- 批准号:
9560504 - 财政年份:1996
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
GRGC: Holocene Paleoenvironments in the Central Midwest: Vegetation, Climate, and Landscape Evolution
GRGC:中西部中部全新世古环境:植被、气候和景观演化
- 批准号:
9316391 - 财政年份:1994
- 资助金额:
$ 30万 - 项目类别:
Continuing Grant
Mathematical Sciences: Nonselfadjoint Limit Algebras
数学科学:非自共极限代数
- 批准号:
9401456 - 财政年份:1994
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
Undergraduate Power Laboratory Work Station Upgrade
本科生动力实验室工作站升级
- 批准号:
9050754 - 财政年份:1991
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
Surface Chemical Reaction Techniques for Ultrathin CompositeMembranes
超薄复合膜表面化学反应技术
- 批准号:
9060012 - 财政年份:1991
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
New Coating Techniques for Composite Membranes
复合膜新涂层技术
- 批准号:
8960966 - 财政年份:1990
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
Mathematical Sciences: Triangular AF Algebras and TriangularHyperfinite Algebras
数学科学:三角AF代数和三角超有限代数
- 批准号:
9196026 - 财政年份:1990
- 资助金额:
$ 30万 - 项目类别:
Continuing Grant
相似国自然基金
Sex-lethal基因在斑翅果蝇性别决定中的作用及雌性特异致死品系构建
- 批准号:2022JJ40269
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
肿瘤抑制分子Lethal Giant Larvae 1 (Lgl1) 促进中枢神经元轴突损伤后再生
- 批准号:31871036
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
基因lethal giant larvae调节果蝇卵巢滤泡上皮组织的模式建成及形态发生的机理研究
- 批准号:31071289
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
相似海外基金
CAREER: Branched Amphiphilic Peptide Capsules (BAPCs) for the delivery of lethal dsRNA into invasive organisms
事业:分支两亲肽胶囊 (BAPC) 用于将致命的 dsRNA 传递到入侵生物体中
- 批准号:
2340070 - 财政年份:2024
- 资助金额:
$ 30万 - 项目类别:
Continuing Grant
Identification of immune cells protecting from lethal viral infection in the central nervous system
鉴定中枢神经系统免受致命病毒感染的免疫细胞
- 批准号:
22KJ1176 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Contemporary Long-Term Homicide Trends in England and Wales in the Period 1977-2019 and a Comparison with Non-Lethal Violence Trends
1977-2019 年英格兰和威尔士当代长期凶杀趋势以及与非致命暴力趋势的比较
- 批准号:
ES/X000575/1 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Research Grant
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
- 批准号:
23K14885 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Etiology and pathogenesis of lethal lung developmental disorders in neonates
新生儿致命性肺发育障碍的病因和发病机制
- 批准号:
10660107 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Epigallocatechin gallate for prevention of lethal cirrhosis complications
表没食子儿茶素没食子酸酯用于预防致命性肝硬化并发症
- 批准号:
10713745 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Conditional male lethal Anopheles stephensi line for the efficient manufacture of malaria vaccines
用于高效生产疟疾疫苗的条件性雄性致死史氏按蚊品系
- 批准号:
10602811 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Lethal Psi: Characterising critical embolism thresholds for Amazon tree survival
Lethal Psi:描述亚马逊树木生存的关键栓塞阈值
- 批准号:
NE/X001164/1 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Research Grant
Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer
前列腺基质基因表达的综合表征及其与致死性前列腺癌的关联
- 批准号:
10759608 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer
DNA 损伤修复 (DDR) 缺陷的致死性前列腺癌的功能表征和治疗范例的开发
- 批准号:
10675929 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别: